Abstract
For patients with postoperative lymph node (LN) recurrent esophageal cancer, the appropriate irradiation field in chemoradiotherapy (CRT) remains controversial. We assessed the clinical outcomes and prognostic factors related to involved-field CRT for postoperative solitary LN recurrence of esophageal squamous cell carcinoma (ESCC). We retrospectively evaluated 21 patients who had received curative resection, with LN recurrence of ESCC. Patients received CRT using 5-fluorouracil plus cisplatin or docetaxel, prescribed at 60 Gy in 30 fractions. We evaluated the pattern of failure, toxicities, survivals, and prognostic factors. We defined elective nodal failure (ENF) as recurrence in a regional LN without involved-field failure. The median follow-up duration was 32 months (range, 4-106 months). Nine patients experienced failure-4 (19%) within involved-field and 5 (24%) with distant metastasis. No patients had ENF. We observed no severe toxicities. The 2-year overall survival (OS) rate was 78%. In the univariate analysis of OS, two factors, the maximal diameter of the metastatic LN < 25 mm and the absence of serum p53 antibodies (s-p53-Abs), were associated with a significantly better prognosis (p = 0.025 and p = 0.01, respectivel...Continue Reading
References
Mar 1, 1997·World Journal of Surgery·M S BhansaliK Shirouzu
May 11, 1999·JAMA : the Journal of the American Medical Association·J S CooperL L Leichman
Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·A TrottiW Curran
Aug 17, 2000·Journal of the American College of Surgeons·J B HulscherJ J van Lanschot
Nov 3, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K NemotoY Hosoi
Jul 12, 2002·Surgery·Hideaki ShimadaTakenori Ochiai
Mar 26, 2003·Cancer·Christophe MarietteJean-Pierre Triboulet
Dec 3, 2003·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Hiroyuki KatoHiroyuki Kuwano
Feb 5, 2004·Journal of the American College of Surgeons·Satoru NakagawaKatsuyoshi Hatakeyama
Mar 7, 2006·BMC Cancer·Keiichi JinguShogo Yamada
Jul 2, 2008·Annals of Surgical Oncology·Tsutomu NakamuraNorio Mitsuhashi
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jan 6, 2010·Japanese Journal of Clinical Oncology·Yuzuru Niibe, Kazushige Hayakawa
Feb 23, 2010·International Journal of Radiation Oncology, Biology, Physics·Jin-Cheng LuHua Tao
Apr 3, 2010·Langenbeck's Archives of Surgery·Shoji NatsugoeSumiya Ishigami
Nov 23, 2012·BMC Cancer·Keiichi JinguKenji Nemoto
Dec 5, 2012·Bone Marrow Transplantation·Y Kanda
Jan 21, 2014·Radiation Oncology·Dai-yuan MaYou Lu
Dec 30, 2014·Cancer Chemotherapy and Pharmacology·Tatsuya MiyazakiHiroyuki Kuwano
Feb 6, 2016·Radiation Oncology·Minghuan LiJinming Yu
Dec 30, 2016·Japanese Journal of Clinical Oncology·Keiichi JinguKen Takeda
Sep 15, 2017·Japanese Journal of Clinical Oncology·Takuya KimotoKei Yamada
Dec 1, 2017·Japanese Journal of Clinical Oncology·Terufumi KawamotoKatsuyuki Karasawa